COMMUNIQUÉS West-GlobeNewswire

LHC Group to Present at 36th Annual J.P. Morgan Healthcare Conference

04/01/2018 - 17:15

LAFAYETTE, La., Jan. 04, 2018 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG ) announced today that Keith G. Myers, chief executive officer of LHC Group, will present at the 36 th Annual J.P. Morgan Healthcare [...]

Tempus and Vanderbilt-Ingram Cancer Center Announce Data Initiative to Improve Outcomes for Cancer Patients

04/01/2018 - 17:00

CHICAGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, and Vanderbilt-Ingram [...]

NeuroMetrix CEO to Participate in CES 2018 Panel on Opioid Crisis

04/01/2018 - 17:00

WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will participate in a panel at the Digital [...]

WishBone Medical, Inc. Names Andrew J. Miclot as President

04/01/2018 - 16:19

WARSAW, Ind., Jan. 04, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants in sterile packed, single-use [...]

INC Research/inVentiv Health Becomes Syneos Health™

04/01/2018 - 15:28

RALEIGH, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq: INCR ) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More than 21,000 of the [...]

CASMED Reports Preliminary Net Sales for the 2017 Fourth Quarter

04/01/2018 - 15:21

BRANFORD, Conn., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the [...]

Ultragenyx Announces Update to UX007 Development Program in Long-Chain Fatty Acid Oxidation Disorder Patients

04/01/2018 - 15:08

NOVATO, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Sienna Biopharmaceuticals to Present at J.P. Morgan Healthcare Conference

04/01/2018 - 15:05

WESTLAKE VILLAGE, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA ) today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of [...]

Houston Dermatologist Reveals Laser Treatment Options for Birthmarks

04/01/2018 - 15:01

HOUSTON, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Most birthmarks, including Becker’s Nevus and Nevus of Ota , do not pose a threat to one’s health, explains Houston dermatologist Paul M. Friedman, MD. However, he says that [...]

Adverum Biotechnologies Provides 2018 Outlook

04/01/2018 - 15:00

MENLO PARK, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, today [...]

Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer

04/01/2018 - 15:00

ROCKVILLE, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today [...]

WellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare Costs

04/01/2018 - 15:00

COLUMBIA, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital therapeutic with type [...]

CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery

04/01/2018 - 15:00

OXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative, inspired by the [...]

Envigo Allocates $300 Million Term Loan B Facility

04/01/2018 - 15:00

EAST MILLSTONE, N.J., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Envigo , a leading provider of non-clinical contract research services and research models, today announced it has allocated a $300 million offering of senior [...]

A Profound Vision of the Future: eSight Pledges to Make Blindness History by 2020

04/01/2018 - 15:00

LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- eSight is proud to announce that it is launching a global pledge to Make Blindness History by the year 2020. This profound commitment marks the launch of a global effort to [...]

Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split

04/01/2018 - 15:00

TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSX-V: SCYB ) (Frankfurt: 9SB ) (OTC Pink:SCCYF) announces that its Board of Directors has approved a proposed up [...]

Crinetics Pharmaceuticals Appoints Marc Wilson as Chief Financial Officer

04/01/2018 - 15:00

SAN DIEGO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced the appointment of Marc [...]

AXIM Biotech Attends Biotech Showcase Conference in San Francisco

04/01/2018 - 15:00

NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief [...]

Predictive Technology Group Appoints Dr. Hugh S. Taylor, M.D. to the Predictive Technology Group's Scientific Advisory Board

04/01/2018 - 15:00

SALT LAKE CITY, Utah, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Dr. Hugh S. Taylor, M.D., joined the Predictive Technology Group’s Scientific Advisory Board. [...]